ORAGENICS, INC. Other Nonoperating Expense
ORAGENICS, INC. (OGEN) reported Other Nonoperating Expense of $603.01 thousand for the 12-month period ending 2010-12-31, per its 10-K filed 2012-04-16.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2012-04-16
- ORAGENICS, INC. other nonoperating expense for fiscal 2010 was $603.01K.
| Period end | Other Nonoperating Expense 12 month |
|---|---|
| 2010-12-31 | $603.01K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |